AGER
Reaktivität: Human
WB, IF
Wirt: Kaninchen
Polyclonal
RB21217
unconjugated
Applikationshinweise
ELISA: >1:260,676, IHC-P: >1:400, WB: >1:3,000 Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
Supplied as liquid whole serum without preservative
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Target
RAGE (AGER)
(Advanced Glycosylation End Product-Specific Receptor (AGER))
Andere Bezeichnung
RAGE
Hintergrund
The Receptor for Advanced Glycosylated End Products (RAGE) is a member of the immunoglobulin superfamily of cell surface molecules that binds molecules that have been irreversibly modified by non-enzymatic glycation and oxidation, and are know as advanced glycation end products (AGEs). It is expressed by endothelium, mononuclear phagocytes, neurons and smooth muscle cells. Whereas RAGE is present at high levels during development, especially in the central nervous system, its levels decline during maturity.